CliffBio
small molecule

NYSTATIN AND TRIAMCINOLONE ACETONIDE

NYSTATIN; TRIAMCINOLONE ACETONIDE

Loss of exclusivity—loss of exclusivity
CompanyAlembic →See this company's full patent-cliff portfolio

Drug detail

Brand nameNYSTATIN AND TRIAMCINOLONE ACETONIDE
Active ingredientNYSTATIN; TRIAMCINOLONE ACETONIDE
Strength100,000 UNITS/GM;0.1%
Dosage formCREAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalMarch 2021
Marketing statusRX

More from Alembic

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.